GLP-1 and cellular homeostasis in aging Glucagon-like peptide-1 (GLP-1) is a gut hormone with significant roles beyond regulating blood sugar. It may play a crucial role in maintaining cellular homeostasis, particularly during aging. Aging and its related disorders may cause severe health problems, finding new and efficient treatments is essential to managing diseases associated with aging and slowing down the aging process. GLP-1 receptor agonist is one of the classes of anti-diabetic drug, recommended to manage aging-related GLP-1 and age-related diseases Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone with surprising potential in tackling various age-related diseases. Initially known for its role in regulating blood sugar levels in type 2 diabetes, GLP-1 has emerged as a promising player in managing and potentially preventing a range of diseases associated with aging. GLP-1 and cognitive function The 30-amino acid peptide hormone known as GLP-1 is created by intestinal epithelial endocrine L-cells through the digestion of proglucagon [55]. GLP-1 is frequently used to treat type 2 diabetes because it can lower body weight in addition to controlling blood glucose. GLP-1 may also be used in the future to treat obesity and type 1 diabetes mellitus as an adjuvant treatment when used in conjunction with insulin [56]. Naturally occurring GLP-1 has very limited effects because it breaks down in И ссылка на полный документ: https://www.sciencedirect.com/science/article/abs/pii/S0378512224001233#:~:text=While%20GLP%2D1%20works%20through,the%20management%20of%20healthy%20aging.
Нет, не годится, там речь о процессах при синдроме Вольфрама, и нейродегенеративных процессах, связанных с ним, а не просто антиэйдж в вакууме.
Перейти в ветку обсуждения в Telegram